Jason James, MD
Obstetrics & Gynecology · Miami, FLNPI 1679522619
Payments from drug & device makers
Across 222 payments — averaging $434.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$45K
- Sage Therapeutics, LLC$41K
- Radiometer America, Inc$3K
- Baxter Healthcare$2K
- Roche Diagnostics Corporation$2K
- AbbVie$745
- plus $3K from 25 others
What the payments were for
- Consulting fees$36,41238%
- Speaking & faculty fees$42,79144%
- Travel & lodging$12,13613%
- Food & beverage$4,9285%
- Education$2600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 48 | $45,096 |
| Sage Therapeutics, LLC | 60 | $40,941 |
| Radiometer America, Inc | 2 | $2,694 |
| Baxter Healthcare | 2 | $2,420 |
| Roche Diagnostics Corporation | 1 | $2,000 |
| AbbVie(2 entities) | 27 | $745 |
| Astellas Pharma US Inc | 15 | $480 |
| BD | 2 | $361 |
| Mayne Pharma Commercial LLC | 9 | $269 |
| Hologic Sales And Service, LLC | 7 | $209 |
| Myriad Women's Health, Inc. | 1 | $173 |
| Covidien LP | 1 | $126 |
| Exeltis, USA Inc. | 5 | $126 |
| Bayer | 4 | $100 |
| Myovant Sciences Inc. | 4 | $99 |
| Coopersurgical, Inc. | 5 | $97 |
| Medline Industries LP | 4 | $75 |
| Gynesonics, Inc. | 1 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Therapeuticsmd, Inc. | 3 | $57 |
| Novo Nordisk | 3 | $56 |
| Pfizer | 2 | $49 |
| Duchesnay USA Incorporated | 3 | $42 |
| Avion Pharmaceuticals | 2 | $26 |
| Cepheid | 1 | $25 |
| Intra-sana Laboratories | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Organon | 2 | $18 |
| Meditrina | 1 | $15 |
| Alydia Health | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZULRESSO$40,333
- Zurzuvae$29,508
- Non-Franchise (NOF) - NonProduct$2,400
- SPINRAZA$2,210
- Skyclarys$2,210
- CD cobas Reagents$2,000
- myRisk$173
- TruClear$126
- ORIAHNN$124
- Orilissa$113
How this compares
$96,527 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $717 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $164 |
| ProgesteroneProgesterone, Micronized | 12 | $134 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Miami
- Guillermo LievanoMiami$2.5M
- Victoria BedellMiami$1.4M
- Sarah BedellMiami$1.1M
- Luis LeyvaMiami$754K
- Joanna BedellMiami$575K
- Julio ArronteMiami$290K
- Beatrice HeckerMiami$172K
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Steven McCarusCelebration$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.